Retrospective analysis of results of treatment of 91 cancers of the oral cavity (1982-1992);Analyse retrospective des resultats du traitement de 91 cancers de la cavite buccale de 1982 a 1992

Cancer/Radiotherapie

Volumn 4, Issue 1, 2000, Pages 32-39

  Pradier, O ^a   Hummers Pradier, E ^a   Gaci, Z ^b   Jadaud, D ^b   Descrozailles, J M ^b   Gesta, P ^c   Germain, T ^b   Daban, A ^b   Hess, C F ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c Service de Radiothérapie   (France)

Author keywords

Low dose rate brachytherapy; Oral cavity; Radiotherapy; Surgery

Indexed keywords

ARTICLE; BONE NECROSIS; CANCER STAGING; CANCER SURVIVAL; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TONGUE CARCINOMA; TREATMENT OUTCOME; ADJUVANT THERAPY; ADULT; AGED; BRACHYTHERAPY; FEMALE; MALE; MIDDLE AGED; MOUTH TUMOR; PROGNOSIS; SURVIVAL; TONGUE TUMOR; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENT;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TONGUE NEOPLASMS; TREATMENT OUTCOME;

EID: 0033649458     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(00)88650-3     Document Type: Article

References (38)

1. Akine Y, Tokita N, Ogino T, Tsukiyama I, Egawa S, Saikawa M, et al. Stage I-II carcinoma of the anterior two-thirds of the tongue treated with different modalities: A retrospective analysis of 244 patients. Radiother Oncol 1991; 21: 24-8.
2. Al-Sarraf M. Head and neck cancer: Chemotherapy concept. Semin Oncol 1988; 15: 70-85.
3. Baillet F, Delouche G, Bachelot F. Résultats d'une étude multicentrique concernant 968 épithéliomas du plancher de la bouche. J Eur Radiothér 1982; 3: 147-52.
4. Bartelink H, Breur K, Hart G, Annyay B, van Slooten E, Snow G. The value of postoperative radiotherapy as an adjuvant radical neck dissection. Cancer 1983; 52: 1008-13.
5. Begg AC, Hoffland J, Van Glabekke M, Barthlink H, Horiot JC. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from EORTC trial 22851. Sem Radiat Oncol 1992; 2: 22-85.
6. Benk V, Mazeron JJ, Grimard L, Crook J, Haddad E, Piedbois P, et al. Comparison of curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinoma of the mobile tongue. Radiother Oncol 1990; 18: 339-48.
7. Bradfield JS, Scruggs RP. Carcinoma of the mobile tongue: Incidence of cervical metastases in early lesions related to method of primary treatment. Laryngoscope 1983; 93: 1332-6.
8. Brown B, Barnes L, Mazariegos J, Taylor F, Johnson J, Wagner RL. Prognostic factor in mobile tongue and floor of mouth carcinoma. Cancer 1989; 64: 1195-202.
9. Brugère J, Poncet P, Guédon C, Point D, Laurent M, Asselain B. L'envahissement ganglionnaire des carcinomes épidermoïdes de la langue mobile. Bilan de 502 évidements ganglionnaires. Actual Carcinol Cervicofaciale 1983; 94-100.
10. Decroix Y, Ghossein N. Experience of the Curie Institute in treatment of cancer of the mobile tongue. Stage II. Cancer 1981; 47: 496-502.
11. Dubray B, Mosseri V, Brunin F, Jaulerry C, Poncet P, Rodriguez J, et al. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: A prospective study. Radiology 1996; 201: 553-8.
12. Dutreix A, Marinello G, Wanbersie A. Dosimétrie en Curiethérapie. Paris: Masson; 1982. p. 109-38.
13. Fein DA, Mendenhall WM, Parsons JT. Carcinoma of the oral tongue. A comparison of results and complication of treatment with radiotherapy and/or surgery. Head Neck 1994; 16: 358-65.
14. Fletcher GH. Textbook of Radiotherapy. 3rd Ed. Philadelphie: Lea and Febiger; 1980. p. 305-15.
15. Franceschi D, Gupta R, Spiro RH, Shah JP. Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg 1993; 166: 360-5.
16. Gomez R, El Naggar AK, Byers RM, Garnsey L, Luna MA, Batsakis JG. Squamous carcinoma of oral tongue: Prognostic significance of flow cytometric DNA content. Mod-Pathol 1992; 5: 141-5.
17. Grimard L, Mazeron JJ, Pierquin B. Comparison of curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinomas of the floor of mouth. Endocur Hypertherm Oncol 1991; 7: 97-103.
18. Haddad E, Mazeron JJ, Vergnes L, Brun B, Piedbois P, Le Péchoux C, et al. Concurrent radiochemotherapy in advanced head and neck cancer: Preliminary results of a phase III trial. Proc Am Soc Clin Oncol 1992; 11: 241.
19. Haie C, Gerbaulet A, Wibault P, Chassagne D, Marandas P. Résultats de la curiethérapie et de l'association radiothérapie transcutannée, curiethérapie, dans 158 cas de cancers de la langue mobile. Expérience de l'institut Gustave-Roussy de 1970 à 1978. Actual Carcinol Cervicofacial 1983; 9: 53-7.
20. Horiot JC, La Fur R, Schraub S, Van der Boegaert W, Van Glabekke M, Pierat M, Begg AC. Status of the experience of the EORTC group of radiotherapy with hyperfractionated and accelerated radiotherapy regimen. Sem Radiat Oncol 1992; 2: 34-7.
21. Lusinchi A, Cosset JM, Wibault P, Marandas P, Eschwège F. Résultats à long terme d'une irradiation pentafractionnée dans les cancers avancés de la cavité buccale et de l'oropharynx. Bull Cancer Radiother 1991; 78: 217-22.
22. Mazeron JJ, Baillet F, Géhanno P, Brun B. Les cancers de la cavité buccale. In: Stratégie Thérapeutique en Cancérologie. Paris: Le Bourgeois JP, éd: 1986. p. 37-44.
23. Mazeron JJ, Grimard L, Raynal M, Haddad E, Piedbois P, Martin M, et al. Iridium 192 curietherapy for T1 and T2 epidermoid carcinomas of the floor of the mooth. Int J Radiat Oncol Biol Phys 1990; 18: 1299-306.
24. Mazeron JJ, Le Floch O. Traitement des carcinomes épidermoïdes de la langue mobile et du plancher buccal. Bull Cancer Radiothér 1992; 79: 379-90.
25. Mazeron JJ, Martin M, Brun B, Grimard L, Lelievre G, Haddad E, et al. Induction chemotherapy in head and neck cancer: Results of a phase III trial. Head Neck 1992; 14: 85-91.
26. Mazeron JJ, Simon JM, Le Péchoux C, Crook JM, Grimard L, Piedbois P, et al. Effect of dose rate on local control and complications in definitive irradiation of T1-T2 squamous cells carcinoma of mobile tongue and floor of mooth with interstitial iridium 192. Radiother Oncol 1991; 21: 39-47.
27. Mendenhall WM, Parson JT, Stringer SP, Cassisi NJ, Million RR. T2 oral tongue carcinoma treated with radiotherapy: Analysis of local control and complications. Radiother Oncol 1989; 16: 275-81.
28. Mirabel X, Coche B, Moncho V, Castelain B, De Cordoue X, Lefévre JL, et al. Curiethérapie des cancers de la cavité buccale. Dix ans d'expérience au centre Oscar-Lambret. Bull Cancer Radiothér 1992; 79: 392-8.
29. Pernot M, Malissard L, Aletti P, Hoffstetter S, Forçard JJ, Bey P. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: Comparaison of two treatment techniques. Radiother Oncol 1992; 23: 223-8.
30. Pernot M, Verhaeghe JL, Guillemin F, Carolus JM, Hoffstetter S, Peiffert D. Évaluation de l'importance d'un curage ganglionnaire systématique dans les carcinomes de la cavité buccale traités par curiethérapie seule pour la lésion primaire (À propos d'une série de 346 patients). Bull Cancer Radiothér 1995; 82: 311-7.
31. Piedbois P, Mazeron JJ, Haddad E, Coste A, Levy C, Raynal M, et al. Stage I-II squamous cell carcinoma of the oral cavity treated by iridium 192: Is elective neck dissection indicated? Radiother Oncol 1991; 21: 100-7.
32. Simon JM, Calais G, Beutter P, Goga D, Chapet S, Bougnoux AR, et al. Valeur pronostique du statut ganglionnaire histologique des carcinomes de la cavité buccale. Bull Cancer Radiothér 1992; 79: 392.
33. Spiro RH, Strong EW. Epidermoid carcinoma of the mobile tongue. Treatment by partial glossectomy alone. Am J Surg 1971; 122: 707-10.
34. Tannock IF, Browman G. Lack of evidence for a role of chemotherapy in the routine management of localy advanced head and neck cancer. J Clin Oncol 1986; 4: 1121-6.
35. Taylor SG IV. Why has so much chemotherapy done so little in head and neck cancer? J Clin Oncol 1987; 5: 1-13.
36. Taylor SG IV, Murthy A, Showel J, Griem S, Hartsell W, Kiel M, et al. Analysis of sequential versus simultaneous radiation in unresectable head and neck cancer: ICC and PCP studies. Proc Am Soc Clin Oncol 1992; 11: 241.
37. Vandenbrouck C, Sancho-Garnier H, Chassagne D, Saravane D, Cachin Y, Micheau C. Elective versus therapeutic radical neck dissection in epidermic carcinoma of the oral cavity: Results of a randomized clinical trial. Cancer 1980; 46: 386-90.
38. Wendt CD, Peters LJ, Delclos L, Ang KK, Morrison WH, Maor MH, et al. Primary radiotherapy in the treatment of stage I and II oral cancers; importance of the proportion of therapy delivered with interstitial therapy. Int J Radiat Oncol Biol Phys 1990; 18: 1287-92.